SCHEMBL13005487

SCHEMBL13005487

CC(C)Cc1cccc(CN(C(C)C)[C@@H](Cc2ccccc2)CN(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.40
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
OPRK1 P41145 2/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
HTR2A P28223 1/20 0.39
ADRA1A P35348 1/20 0.39
KCNH2 Q12809 1/20 0.39
MAOA P21397 4/20 0.37
SIGMAR1 Q99720 3/20 0.37
TAAR1 Q96RJ0 2/20 0.37
CYP2A6 P11509 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13060671 0.89 OPRK1 (0.39) SLC6A2SLC6A4SLC6A3OPRK1ADRA2B
SCHEMBL13005484 0.86 OPRK1 (0.47) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005495 0.85 OPRK1 (0.43) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005492 0.82 TSHR (0.42) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005494 0.81 ALOX5 (0.41) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005518 0.78 CETP (0.40) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005557 0.76 SIGMAR1 (0.41) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005605 0.76 SLC6A2 (0.45) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL16640979 0.76 ALDH1A1 (0.50) CETPSLC6A2SLC6A4SLC6A3OPRK1
SCHEMBL13005515 0.75 CETP (0.40) CETPSLC6A2SLC6A4SLC6A3OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed